By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



7557 Rambler Road
Suite 700
Dallas  Texas  75231  U.S.A.
Phone: 214-731-3141 Fax: 214-731-3149


Company News
ImmunoCellular Therapeutics (IMUC) And Memgen Announce Letter Of Intent For Potential Joint Immuno-Oncology Collaboration 3/23/2017 8:28:32 AM
Memgen Announces Preclinical Results For Its ISF35 Cancer Immunotherapy With Checkpoint Inhibitors In Metastatic Melanoma 11/18/2015 8:25:48 AM
Memgen Announces Upcoming Presentation for ISF35 in Chronic Lymphocytic Leukemia at 2011 Memgen Annual Meeting 12/9/2011 6:40:41 AM
Memgen Announces Clinical and Preclinical Results for ISF35 in Chronic Lymphocytic Leukemia and Non-Hodgkin's Lymphoma 12/9/2010 9:09:52 AM
Memgen's ISF35 Sensitizes Leukemia Cells to Chemotherapy 12/8/2009 10:57:26 AM
Memgen's Clinical Trial Results of ISF35 for Chronic Lymphocytic Leukemia Selected for Presentation at American Society of Hematology 2009 Annual Meeting 12/1/2009 1:38:26 PM
Memgen Reports Positive Results for ISF35 in High-Risk Chronic Lymphocytic Leukemia 6/4/2009 1:59:47 PM
Memgen's ISF35 Clinical Trial Featured at American Society of Clinical Oncology Annual 2009 Meeting 5/26/2009 2:07:19 PM
Memgen's Clinical Results on Leukemia Selected for Presentation at 2008 American Society of Hematology Annual Meeting 12/3/2008 9:38:13 AM